Cristalia Pharmaceutical Chemical Products Laboratories

Cristalia, as a Pharmaceutical company associated with INCT-INOFAR, is responsible for the pharmacotechnical stages of development of eventual compound-prototypes that have reached this stage of the chain of innovation. Under terms of confidentiality, Cristalia will benefit from the privileged conception of projects, by always being the first company consulted for possible partnerships. In case Cristalia does not want to produce the molecule, the Institute is fully free to present it to another pharmaceutical industry.
http://www.2cristalia.com.br/

Royal Institute

Toxicology is a very delicate stage that can absolve or condemn a molecule. INCT-INOFAR prioritizes studies of genotoxicity and acute toxicology as early as possible in the chain of innovation in pharmaceuticals. To assure that all the stages of pre-clinical toxicology are accredited in Good Laboratory Practices (BPL), INCT-INOFAR has partnered with Royal Institute, the result of the merger between two toxicology laboratories incubated in different universities. Genotox-Royal Institute, in UFRGS, conducts the genetic toxicity studies, while Unitox-Royal, in University of Santo Amaro (Unisa-SP), is responsible for the animal toxicity tests.
http://www.institutoroyal.org.br

In Vitro Cells

In Vitro Cells – Toxicology Research S.A. is a technology base company located in Biominas Foundation (Belo Horizonte, MG). Their founders are professors of the Federal University of Minas Gerais, in the areas of Toxicology and Biochemistry. The company is a INOFAR partner in the conduction of in vitro tests for the evaluation of the safety and efficacy of pharmaceutical candidates developed by the Institute.
http://www.invitrocells.com.br